Want to join the conversation?
Steve Scala with Cowen asks about the upcoming KEYTRUDA PDUFA in head and neck cancer, should it be assumed approval will be only for third line PD-L1 positive patients. $MRK said in terms of approval, it cannot be commented what exactly the label will look like.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.